For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Going low in ChIP

Related

  • ChIP protocols
    • Cross-linking ChIP
      • Native ChIP
        • ChIP troubleshooting tips
          • Chromatin preparation from tissues for ChIP
            • ChIP tips and tricks
                • Tools for your research
                  • Protocols library
                    • ChIP kits
                      • ChIP-grade antibodies

                          ​Novel strategies for chromatin immunoprecipitation (ChIP) with low input samples.

                          ​Standard ChIP workflows require a starting sample quantity of around 106 to 107 cells, below which the assay is hindered by high background binding, poor enrichment efficiencies and loss of enriched library complexity.

                          ​

                          Improving enrichment efficiency and sample loss

                          To counter this, several adjustments to the ChIP workflow have been proposed for low input samples to increase enrichment efficiency1 and minimize sample loss2​.

                          • The quality and properties of the sample itself are important considerations, and often the starting material is formalin-fixed paraffin embedded (FFPE) in which over-cross-linking can cause problems. Methods to extract soluble chromatin from FFPE samples have been developed3.
                          • The many variables that affect the kinetics of the immunoprecipitation with low concentration antigen can be optimized, including buffer pH, ionic strength and time of incubation4.
                          • Micrococcal nuclease (MNase) is an endo-exonuclease that digests DNA until it meets some obstruction, such as a nucleosome or bound protein. MNase can be used instead of, or in addition to limited sonication to shear the cross-linked DNA and avoid the broad fragment size distribution that hinders low-input ChIP5.
                          • While bacterial DNA is sometimes used as a blocking agent for standard ChIP, it is not advised for low-input ChIP as it carries through the assay and confounds data analysis. Other blocking agents such as inert proteins or mRNA can reduce background binding in low-input ChIP, without contaminating the data2.
                          • Miniaturization of the assay into microwell formats facilitates automation and increases concentration of the antigen (target transcription factor) during the IP workflow –  this avoids the “dilution effect” of low antigen concentrations that favor dissociation of the antibody:antigen complex4 and decrease the efficiency of ChIP.
                          • Single-tube assay formats and the use of magnetic or SPRI bead purification rather than phenol-based extraction after each assay step maximizes sample retention.
                          • Often overlooked steps are the immobilization of antibody and washes to remove non-antibody bound material. Standard protocols use Protein A/G for this purpose. Alternatives have suggested the use of epitope tagged proteins6, but these run the risk of over-expression and the introduction of artefacts.

                            ​The Abcam high-sensitivity ChIP assay employs a unique chimeric protein to capture the antibody-bound protein:DNA complex and this offers significant advantage: the capture protein is smaller than Protein A or G and is coated at high density on the surface of microtiter plate wells, providing a much higher number of IgG immobilization sites in a smaller area, which in turn ensures efficiency and concentration of eluted DNA. In addition, the chimeric capture protein shows superior stability across a wider range of pH and salt concentrations, which allows higher stringency wash conditions to be used.


                          Platform choice and downstream sample processing

                          In addition to the assay itself, the choice and optimization of downstream processing (ie sequencing, array, or PCR) and bioinformatic analysis are also important.

                          See also Advances in ChIP-seq analysis with small samples 

                          • The choice of detection platform will impact the sensitivity of the assay. ChIP-sequencing (ChIP-seq) has become the gold standard platform for high sensitivity ChIP, because it gives consistently lower noise than ChIP-on-chip7
                          • The most common issues in low-input ChIP-seq are high numbers of unmappable reads and PCR duplicates, and poor library complexity. While the latter will be helped by maximizing the efficiency of ChIP enrichment as described above, library preparation for sequencing must also be optimized for low input samples, key steps being the optimization of adapter ligation 8,9 and avoidance of amplification-derived error and bias.
                          • Bioinformatic workflows should be adapted to take into account likely process-derived biases in the data10​​​.


                          ​The Abcam high-sensitivity ChIP assay

                          Embarking on ChIP with low sample input quantities can be a daunting prospect. Our high-sensitivity ChIP kit (ab185913) has been developed specifically for this application:

                          • Successful ChIP starting with just 2 x 103 cells or 0.5 mg tissue
                          • Relative enrichment factors >500x
                          • Rapid, 5-hour protocol from cells/tissue to enriched DNA
                          • Microplate assay format for flexibility in sample throughput and automation (can be used in single-well, 8-well strip or 96-well plate format)
                          Successful ChIP starting with just 2 x 103 cells or 0.5 mg tissue
                          Relative enrichment factors >500x
                          Rapid, 5-hour protocol from cells/tissue to enriched DNA
                          Microplate assay format for flexibility in sample throughput and automation (can be used in single-well, 8-well strip or 96-well plate format)


                          Find more ChIP resources



                          References 

                          1. Mao. Accounting for immunoprecipitation inefficiences in the statistical analysis of ChIP-Seq data. BMC Bionformatics. 14, 169 (2013).

                          2. Dirks, R. Genome-wide epigenomic profiling for biomarker discovery. Clinical Epigenetics. 8, 122. (2016).

                          3. Cejas, P. Chromatin Immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles. Nature Medicine. 22, 685. (2016).

                          4. Reverberi, R. Factors affecting the antigen-antibody reaction. Blood transfusion. 5, 227. (2007).

                          5. Gilfillian, G. Limitations and possibilities of low cell number CHIP-SEQ. BMC Genomcis. 13, 645. (2012).

                          6. Xiong, X. A scalable epitope tagging approach for high throughput ChIP-Seq analysis. ACS Synth biol . (2017, Feb 19).

                          7. ENCODE. (n.d.). ENCODE Platform Comparison. Retrieved from https://genome.ucsc.edu/ENCODE/platform_characterization.html

                          8. Schmidl, C. ChIPmentation: fast, robust, low-input ChIP-Seq for histones and transcription factors. Nature Methods. 12, 963. (2015).

                          9. Bolduc, N. Preparation of low-input and ligation-free librarIes using template-switching technology. In Current protocols in molecular biology (Vol. Unit 7.26). Wiley & Sons. (2016).

                          10. Kidder, B. ChIP-Seq: Technical considerations for obtaining high quality data. Nature Immunology. 12, 918. (2011).

                          11. Stelloo, S. Androgen receptor profiling predicts prostate cancer outcome. EMBO Mol Med. 7, 1450. (2015).





                          Get resources and offers direct to your inbox Sign up
                          A-Z by research area
                          • Cancer
                          • Cardiovascular
                          • Cell biology
                          • Developmental biology
                          • Epigenetics & Nuclear signaling
                          • Immunology
                          • Metabolism
                          • Microbiology
                          • Neuroscience
                          • Signal transduction
                          • Stem cells
                          A-Z by product type
                          • Primary antibodies
                          • Secondary antibodies
                          • Biochemicals
                          • Isotype controls
                          • Flow cytometry multi-color selector
                          • Kits
                          • Loading controls
                          • Lysates
                          • Peptides
                          • Proteins
                          • Slides
                          • Tags and cell markers
                          • Tools & Reagents
                          Help & support
                          • Support
                          • Make an Inquiry
                          • Protocols & troubleshooting
                          • Placing an order
                          • RabMAb products
                          • Biochemical product FAQs
                          • Training
                          • Browse by Target
                          Company
                          • Corporate site
                          • Investor relations
                          • Company news
                          • Careers
                          • About us
                          • Blog
                          Events
                          • Tradeshows
                          • Conferences
                          International websites
                          • abcam.cn
                          • abcam.co.jp

                          Join with us

                          • LinkedIn
                          • facebook
                          • Twitter
                          • YouTube
                          • Terms of sale
                          • Website terms of use
                          • Cookie policy
                          • Privacy policy
                          • Legal
                          • Modern slavery statement
                          © 1998-2022 Abcam plc. All rights reserved.